Lachaine, J.; Guinan, K.; Aw, A.; Banerji, V.; Fleury, I.; Owen, C.
Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada. Curr. Oncol. 2023, 30, 4483-4498.
https://doi.org/10.3390/curroncol30050339
AMA Style
Lachaine J, Guinan K, Aw A, Banerji V, Fleury I, Owen C.
Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada. Current Oncology. 2023; 30(5):4483-4498.
https://doi.org/10.3390/curroncol30050339
Chicago/Turabian Style
Lachaine, Jean, Kimberly Guinan, Andrew Aw, Versha Banerji, Isabelle Fleury, and Carolyn Owen.
2023. "Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada" Current Oncology 30, no. 5: 4483-4498.
https://doi.org/10.3390/curroncol30050339
APA Style
Lachaine, J., Guinan, K., Aw, A., Banerji, V., Fleury, I., & Owen, C.
(2023). Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada. Current Oncology, 30(5), 4483-4498.
https://doi.org/10.3390/curroncol30050339